463 related articles for article (PubMed ID: 23831154)
1. Urine as a source for clinical proteome analysis: from discovery to clinical application.
Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
[TBL] [Abstract][Full Text] [Related]
2. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
Albalat A; Mischak H; Mullen W
Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry based proteomics in urine biomarker discovery.
Theodorescu D; Mischak H
World J Urol; 2007 Oct; 25(5):435-43. PubMed ID: 17703310
[TBL] [Abstract][Full Text] [Related]
4. Urine in clinical proteomics.
Decramer S; Gonzalez de Peredo A; Breuil B; Mischak H; Monsarrat B; Bascands JL; Schanstra JP
Mol Cell Proteomics; 2008 Oct; 7(10):1850-62. PubMed ID: 18667409
[TBL] [Abstract][Full Text] [Related]
5. Human urine proteome: a powerful source for clinical research.
Zou L; Sun W
Adv Exp Med Biol; 2015; 845():31-42. PubMed ID: 25355567
[TBL] [Abstract][Full Text] [Related]
6. Urine sample preparation in 96-well filter plates to characterize inflammatory and infectious diseases of the urinary tract.
Yu Y; Pieper R
Adv Exp Med Biol; 2015; 845():77-87. PubMed ID: 25355571
[TBL] [Abstract][Full Text] [Related]
7. Proteomics applied to the study of platelet-related diseases: aiding the discovery of novel platelet biomarkers and drug targets.
Parguiña AF; Rosa I; García A
J Proteomics; 2012 Dec; 76 Spec No.():275-86. PubMed ID: 22579745
[TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments.
Metzger J; Schanstra JP; Mischak H
Anal Bioanal Chem; 2009 Mar; 393(5):1431-42. PubMed ID: 18704377
[TBL] [Abstract][Full Text] [Related]
9. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of urinary proteomics/peptidomics.
Albalat A; Mischak H; Mullen W
Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
[TBL] [Abstract][Full Text] [Related]
11. Proteomics and autoimmune kidney disease.
Rovin BH; Klein JB
Clin Immunol; 2015 Nov; 161(1):23-30. PubMed ID: 25979820
[TBL] [Abstract][Full Text] [Related]
12. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
Mischak H; Delles C; Klein J; Schanstra JP
Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
[TBL] [Abstract][Full Text] [Related]
13. Applications of urinary proteomics in biomarker discovery.
Shao C; Wang Y; Gao Y
Sci China Life Sci; 2011 May; 54(5):409-17. PubMed ID: 21455690
[TBL] [Abstract][Full Text] [Related]
14. A proteomic glimpse into human ureter proteome.
Magdeldin S; Hirao Y; Elguoshy A; Xu B; Zhang Y; Fujinaka H; Yamamoto K; Yates JR; Yamamoto T
Proteomics; 2016 Jan; 16(1):80-4. PubMed ID: 26442468
[TBL] [Abstract][Full Text] [Related]
15. Challenges for red blood cell biomarker discovery through proteomics.
Barasa B; Slijper M
Biochim Biophys Acta; 2014 May; 1844(5):1003-10. PubMed ID: 24129076
[TBL] [Abstract][Full Text] [Related]
16. Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.
Pejchinovski M; Hrnjez D; Ramirez-Torres A; Bitsika V; Mermelekas G; Vlahou A; Zürbig P; Mischak H; Metzger J; Koeck T
Proteomics Clin Appl; 2015 Jun; 9(5-6):453-68. PubMed ID: 25641766
[TBL] [Abstract][Full Text] [Related]
17. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.
Mermelekas G; Vlahou A; Zoidakis J
Expert Rev Mol Diagn; 2015; 15(11):1441-54. PubMed ID: 26472065
[TBL] [Abstract][Full Text] [Related]
18. Practical points in urinary proteomics.
Thongboonkerd V
J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
[TBL] [Abstract][Full Text] [Related]
19. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery in mass spectrometry-based urinary proteomics.
Thomas S; Hao L; Ricke WA; Li L
Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
